Results 11 to 20 of about 2,612,633 (288)

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

open access: yesArthritis Research & Therapy, 2021
Highlights • Male sex, cardiac involvement, DLCO 5 mg/l are strong predictors of mortality in systemic sclerosis. • This study shows the survival of subtypes and in particular sine scleroderma. • Sine scleroderma subtype has better survival than diffuse
Sébastien De Almeida Chaves   +13 more
doaj   +2 more sources

Systemic scleroderma. [PDF]

open access: yesThe Medical clinics of North America, 2020
Scleroderma encompasses a wide variety of diseases, including localized scleroderma, overlap syndromes, sclerodermoid conditions, and systemic scleroderma. This article emphasizes the systemic scleroderma.
D. Tuffanelli
semanticscholar   +3 more sources

Mimics of scleroderma

open access: yesIndian Journal of Rheumatology, 2017
Systemic sclerosis is a rare autoimmune connective tissue disorder characterised typically by tightening and tethering of skin. However, several other disorders are also characterised by hardening and thickening of skin.
Kaveri K Nalianda   +3 more
doaj   +1 more source

Modern Pathogenetic Mechanisms of Systemic Scleroderma [PDF]

open access: yes, 2023
Systemic scleroderma is a chronic and often progressive autoimmune inflammation of the connective tissue, characterized by fibrosis of the skin and internal organs, widespread vascular lesions with unknown etiology, and heterogeneous clinical ...
Botirbekov Abdurashid Nazarkulovich
core   +1 more source

Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).

open access: yesThe Lancet Rheumatology, 2021
BACKGROUND Preliminary criteria for the very early diagnosis of systemic sclerosis (VEDOSS) have been previously proposed to identify signs and symptoms in patients with Raynaud's phenomenon.
S. Bellando-Randone   +14 more
semanticscholar   +1 more source

Systemic Scleroderma in Childhood: A Case Report

open access: yesThe Turkish Journal of Gastroenterology, 2014
Juvenile systemic scleroderma is a rare chronic multi-system connective tissue disease in childhood. Although rare in children, it is an important cause of morbidity and mortality.
Aslı ASLAN   +3 more
doaj   +3 more sources

Fibrosing arthropathy in juvenile scleroderma

open access: yesСовременная ревматология, 2021
The group of scleroderma diseases includes a number of clinical entities, the main symptom of which is skin tightening. Scleroderma is a prominent example of these diseases, characterized by excessive synthesis and deposition of collagen in organs and ...
D. A. Dibrov   +2 more
doaj   +1 more source

Localized scleroderma: clinical spectrum and therapeutic update [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2015
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis ...
Mariana Figueiroa Careta, Ricardo Romiti
doaj   +2 more sources

Renal Involvement in Systemic Sclerosis: An Update

open access: yesKidney & Blood Pressure Research, 2020
Background: Systemic sclerosis is an immune-mediated rheumatic disease characterized by vascular abnormalities, tissue fibrosis and autoimmune phenomena.
Magdalena Chrabaszcz   +6 more
doaj   +1 more source

A case of scleroderma-like lesions as a cutaneous manifestation of carcinoid syndrome

open access: yesCurrent Problems in Cancer: Case Reports, 2022
Scleroderma-like lesions are a rare sign of carcinoid syndrome which have been associated with poor prognosis. They differ from systemic sclerosis by involving preferentially the skin in the lower limbs, lacking Raynaud's phenomenon and having no ...
João Boavida Ferreira   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy